1887
Perspective Open Access
Like 0

Abstract

In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been optimally implemented across Europe. Within the European Joint Action on Vaccination (EU-JAV), we conducted a survey to collect information on decision-making process including the main criteria for the introduction of new vaccines or changes to recommendations on their use. Between December 2021 and January 2022, 13 of the 28 European countries invited participated in an online survey. The criteria ranked as most relevant were disease burden and availability of financial resources. Only one country specified that the NITAG recommendations were binding for the government or the health authority. Vaccinations more often reported for introduction or recommendation changes were those against herpes zoster, influenza, human papillomavirus infection, pneumococcal and meningococcal disease. The planned changes will mainly address children and adolescents (2–18 years) and adults (≥ 45–65 years). Our findings show potential overlaps in the activities of NITAGs between countries; and therefore, collaboration between NITAGs may lead to optimisation of the workload and better use of resources.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2023.28.43.2300131
2023-10-26
2024-02-28
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2023.28.43.2300131
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/28/43/eurosurv-28-43-3.html?itemId=/content/10.2807/1560-7917.ES.2023.28.43.2300131&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring. Geneva: WHO; 2014. Available from: https://apps.who.int/iris/handle/10665/111548
  2. Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening. Vaccine. 2010;28(Suppl 1):A18-25.  https://doi.org/10.1016/j.vaccine.2010.02.027  PMID: 20412991 
  3. World Health Organization Regional Office for Europe (WHO/Europe). European Vaccine Action Plan 2015-2020: midterm report. Copenhagen: WHO/Europe; 2018. Available from: https://apps.who.int/iris/handle/10665/340372
  4. World Health Organization (WHO). Guidance for the development of evidence-based vaccination-related recommendations version 8. Geneva: WHO; 2017. Available from: https://cdn.who.int/media/docs/default-source/immunization/sage/general/guidelines-development-recommendations.pdf?sfvrsn=e455fd4b_2&download=true
  5. Donadel M, Panero MS, Ametewee L, Shefer AM. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020. Vaccine. 2021;39(14):1897-909.  https://doi.org/10.1016/j.vaccine.2021.02.059  PMID: 33750592 
  6. European Centre for Disease Prevention and Control (ECDC). Current practices in immunisation policymaking in European countries. Stockholm: ECDC; 2015. Available from: https://data.europa.eu/doi/10.2900/367140
  7. World Health Organization (WHO). National Immunization Advisory Mechanism. Geneva: WHO. [Accessed: 6 Aug 2023]. Available from: https://immunizationdata.who.int/pages/indicators-by-category/national_immunization_advisory_mechanism.html?ISO_3_CODE=&YEAR=
  8. World Health Organization Regional Office for Europe (WHO/Europe). European Immunization Agenda 2030. Copenhagen: WHO/Europe; 2021. Available from: https://www.who.int/europe/publications/i/item/9789289056052
  9. European Centre for Disease Prevention and Control (ECDC). Vaccine Scheduler. Stockholm: ECDC. [Accessed 14 Oct 2022]. Available from: https://vaccine-schedule.ecdc.europa.eu/
  10. Ricciardi GW, Toumi M, Weil-Olivier C, Ruitenberg EJ, Dankó D, Duru G, et al. Comparison of NITAG policies and working processes in selected developed countries. Vaccine. 2015;33(1):3-11.  https://doi.org/10.1016/j.vaccine.2014.09.023  PMID: 25258100 
  11. World Health Organization Regional Office for Europe (WHO/Europe). Guidance on an adapted evidence to recommendation process for National Immunization Technical Advisory Groups. Copenhagen: WHO/Europe; 2022. Available from: https://apps.who.int/iris/handle/10665/356896
  12. Nohynek H, Wichmann O, D Ancona F, VENICE National Gatekeepers. National Advisory Groups and their role in immunization policy-making processes in European countries. Clin Microbiol Infect. 2013;19(12):1096-105.  https://doi.org/10.1111/1469-0691.12315  PMID: 23957860 
  13. Blau J, Sadr-Azodi N, Clementz M, Abeysinghe N, Cakmak N, Duclos P, et al. Indicators to assess National Immunization Technical Advisory Groups (NITAGs). Vaccine. 2013;31(23):2653-7.  https://doi.org/10.1016/j.vaccine.2013.01.047  PMID: 23398930 
  14. Pan American Health Organization/Regional Office for the Americas of the World Health Organization (PAHO/WHO). Operational guide for national immunization technical advisory groups. Washington DC: PAHO/WHO; 2020. Available from: https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf
  15. Steffen CA, Henaff L, Durupt A, Omeiri NE, Ndiaye S, Batmunkh N, et al. Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities. Vaccine. 2021;39(15):2146-52.  https://doi.org/10.1016/j.vaccine.2021.02.055  PMID: 33712350 
  16. Harmon SHE, Faour HD, MacDonald N. National Immunization Technical Advisory Groups (NITAGs): A schema for evaluating and comparing foundation instruments and NITAG operations. Med Law Int. 2021;21(1):69-98.  https://doi.org/10.1177/09685332211002594 
  17. Tavoschi L, Quattrone F, Agodi A, Lopalco PL. Risk of transmission of vaccine-preventable diseases in healthcare settings. Future Microbiol. 2019;14(9s):9-14.  https://doi.org/10.2217/fmb-2018-0236  PMID: 31210537 
  18. European Parliament. Parliament resolution (2017/2951(RSP)) of 19 April 2018 on vaccine hesitancy and the drop in vaccination rates in Europe. Official Journal of the European Union. Luxembourg: Publications Office of the European Union, 18.11. 2019:C 390. Available from: https://eur-lex.europa.eu/ legal-content/EN/TXT/PDF/?uri=OJ:C:2019:390:FULL&from=EN
  19. Squeri R, Di Pietro A, La Fauci V, Genovese C. Healthcare workers’ vaccination at European and Italian level: a narrative review. Acta Biomed. 2019;90(9-S):45-53. PMID: 31517889 
  20. Doherty TM, Connolly MP, Del Giudice G, Flamaing J, Goronzy JJ, Grubeck-Loebenstein B, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9(3):289-300.  https://doi.org/10.1007/s41999-018-0040-8  PMID: 29887922 
  21. Centers for Disease Control and Prevention (CDC). Shingles vaccination. Atlanta: CDC. [Accessed 14 Oct 2022]. Available from: https://www.cdc.gov/vaccines/vpd/shingles/public/shingrix/index.html
  22. Ministry of Health New Zealand. Shingles. Wellington: Ministry of Health New Zealand. [Accessed 14 Oct 2022]. Available from: https://www.health.govt.nz/your-health/conditions-and-treatments/diseases-and-illnesses/shingles
  23. European Centre for Disease Prevention and Control (ECDC). Seasonal influenza vaccination strategies. Stockholm: ECDC. [Accessed: 10 Aug 2022]. Available from: https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/vaccination-strategies
  24. Pebody RG, Sinnathamby MA, Warburton F, Andrews N, Boddington NL, Zhao H, et al. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16. Euro Surveill. 2018;23(25):1700496.  https://doi.org/10.2807/1560-7917.ES.2018.23.25.1700496  PMID: 29945698 
  25. European Centre for Disease Prevention and Control (ECDC). Public consultation on draft guidance for introduction of HPV vaccines in EU countries: focus on 9 valent HPV vaccine and vaccination of boys and people living with HIV. Stockholm: ECDC; 2019. Available from: https://data.europa.eu/doi/10.2900/61383
  26. Kobayashi M, Farrar JL, Gierke R, Britton A, Childs L, Leidner AJ, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):109-17.  https://doi.org/10.15585/mmwr.mm7104a1  PMID: 35085226 
  27. European Centre for Disease Prevention and Control (ECDC). Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA. Stockholm: ECDC; 2017. Available from: https://data.europa.eu/doi/10.2900/18933
  28. World Health Organization (WHO). Defeating meningitis by 2030: a global road map. Geneva: WHO; 2021. Available from: https://apps.who.int/iris/handle/10665/342010
  29. Cassini A, Colzani E, Pini A, Mangen MJJ, Plass D, McDonald SA, et al. , BCoDE consortium. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Euro Surveill. 2018;23(16):17.  https://doi.org/10.2807/1560-7917.ES.2018.23.16.17-00454  PMID: 29692315 
  30. Nijsten D, Houweling H, Durupt A, Adjagba A. Overlapping topics in advisory reports issued by five well-established European National Immunization Technical Advisory Groups from 2011 to 2014. Vaccine. 2016;34(50):6200-8.  https://doi.org/10.1016/j.vaccine.2016.10.082  PMID: 27836436 
  31. European Centre for Disease Prevention and Control (ECDC). EU/EEA National Immunisation Technical Advisory Groups (NITAG) collaboration. Stockholm: ECDC. [Accessed 11 Aug 2022]. Available from: https://www.ecdc.europa.eu/en/about-us/partnerships-and-networks/national-immunisation-technical-advisory-groups-nitag
  32. Colzani E, Johansen K, Johnson H, Pastore Celentano L. Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma. Euro Surveill. 2021;26(50):2001659.  https://doi.org/10.2807/1560-7917.ES.2021.26.50.2001659  PMID: 34915976 
  33. Kahn AL, Steffen CA, Henaff L, MacDonald NE, Morgan C, Faden R, et al. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs). Vaccine. 2023;41(3):676-83.  https://doi.org/10.1016/j.vaccine.2022.11.029  PMID: 36494252 
  34. Europe WHO. National Immunization Technical Advisory Groups (NITAGs). [Accessed 25 Sep 2023]. Available from: https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags)
/content/10.2807/1560-7917.ES.2023.28.43.2300131
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error